SCHEMBL10887841

SCHEMBL10887841

CC1NC(=O)NN=C1c1ccc(-n2cccc2)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PDE3B Q13370 11/20 0.47
▸ PDE3A Q14432 11/20 0.47
▸ PDE4A P27815 2/20 0.47
▸ PDE4B Q07343 2/20 0.47
▸ PDE4C Q08493 2/20 0.47
▸ PDE4D Q08499 2/20 0.47
▸ GPR119 Q8TDV5 2/20 0.45
▸ PDE2A O00408 2/20 0.40
▸ NPC1 O15118 2/20 0.39
▸ RAB9A P51151 2/20 0.39
▸ MAPK1 P28482 1/20 0.39
▸ SMN1; SMN2 Q16637 1/20 0.39
▸ APP P05067 1/20 0.36
▸ KDM4E B2RXH2 1/20 0.34
▸ GAA P10253 1/20 0.34
▸ NPSR1 Q6W5P4 1/20 0.34
▸ L3MBTL1 Q9Y468 1/20 0.34
▸ MGLL Q99685 1/20 0.34
▸ PDE1A P54750 1/20 0.34
▸ PDE1B Q01064 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7319060 0.90 PDE3B (0.46) PDE3BPDE3APDE4APDE4BPDE4C
SCHEMBL10814317 0.79 GPR119 (0.59) PDE3BPDE3APDE4APDE4BPDE4C
SCHEMBL10889047 0.78 PDE3B (0.52) PDE3BPDE3APDE4APDE4BPDE4C
SCHEMBL10809454 0.78 PDE3B (0.54) PDE3BPDE3APDE4APDE4BPDE4C
SCHEMBL10815443 0.76 PDE3B (0.52) PDE3BPDE3APDE4APDE4BPDE4C
SCHEMBL10851310 0.76 PDE3B (0.52) PDE3BPDE3APDE4APDE4BPDE4C
SCHEMBL10809030 0.76 PDE3B (0.58) PDE3BPDE3APDE4APDE4BPDE4C
SCHEMBL9836220 0.76 PDE3B (0.52) PDE3BPDE3APDE4APDE4BPDE4C
SCHEMBL7295733 0.76 PDE3B (0.52) PDE3BPDE3APDE4APDE4BPDE4C
SCHEMBL10891315 0.76 PDE3B (0.67) PDE3BPDE3APDE4APDE4BPDE4C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4616015-A HYPOTENSIVE AGENT, ANTULCER AGENT, ANTICOAGULANT FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1986-10-07 — — US disclosed
EP-0122627-A2 Triazine derivatives, processes for preparation thereof and pharmaceutical compositions comprising the same FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1984-10-24 — — EP disclosed
Send feedback